West Pharmaceutical rises after lifting 2026 profit forecast

West Pharmaceutical Services

23/04/2026 15:19

Updates

** Shares of medical equipment maker West Pharmaceutical WST.N jump 14.8% to $315.28, snapping a two-day losing streak, after raising full-year profit forecast

** Stock on track for its biggest intraday percentage rise in over 6 months, if gains hold

** Co raises FY 2026 adjusted EPS forecast to $8.40 to $8.75 per share, up from its prior forecast of $7.85 to $8.20 per share

** Analysts, on average, were expecting $8.01 per share - LSEG-compiled data

** Posts Q1 adjusted profit of $2.13 per share, above analysts' estimate of $1.68 per share

** "We see the 1Q results as a sticker shock positive update, with organic growth of >15% and EPS ~26% above," Evercore ISI says

** Including session's moves, WST up 14.1% YTD

 (Reporting by Kunal Das in Bengaluru)

 ((Kunal.Das2@thomsonreuters.com;))